Canadian marijuana producer Aurora Cannabis confirmed this week that their products are unavailable in Germany until further notice.

A company spokesperson confirmed to Marijuana Business Daily this week that the products are temporarily unavailable in Germany pending a review by health authorities of “a proprietary step” in the Alberta company’s production process.

German authorities are currently reviewing the method used by the company to ensure shelf life of flowers.

MJBizDaily has corroborated the products’ unavailability with several German pharmacies “until further notice.”

The Aurora Cannabis spokesperson said that the company “stands behind the safety of products previously sold to medical patients and has not initiated a recall.”

They added, “Products for the German market are sourced from an EU GMP certified facility and are safe to consume.”

The company expects sales to restart “very early in the new year.”

German pharmacists have been instructed to stop selling the products until the situation is clarified.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Over 30,000 U.S. Marijuana Users Just Got Affected By A Data Breach
24 January 2020
*Cannabis Breakthrough: Canadian Company Transforming the Global Cannabis Industry with Data-Driven Approach
16 January 2019
Marijuana Sales May Outpace Soda Sales by 2030
05 April 2018